Studieoverzicht
|
BOOG nr.: |
Status: ( View all )
|
Indication: ( View all )
|
Subindication: |
Menopausal status: |
| 2020-01 DESTINY-Breast 06 | Active, not recruiting | Advanced/metastatic | Any HER2, HR+ | Both pre- and postmenopausal | ||||||||||||||
| 2015-03 POSITIVE | Follow up | Adjuvant | Any HER2, HR+ | Premenopausal | ||||||||||||||
| 2006-05 IDEAL | Follow up | Adjuvant | Any HER2, HR+ | Postmenopausal | ||||||||||||||
| 2006-04b TEAM IIb | Follow up | Adjuvant | Any HER2, HR+ | Postmenopausal | ||||||||||||||
| 2006-04a TEAM IIa | Closed | Neoadjuvant | Any HER2, HR+ | Postmenopausal | ||||||||||||||
| 2006-01 DATA | Closed | Adjuvant | Any HER2, HR+ | Postmenopausal | ||||||||||||||
| 2001-01 TEAM | Closed | Adjuvant | Any HER2, HR+ | Postmenopausal |